Academia Sinica academician Chen Pei-jer (陳培哲), who on Monday resigned from the vaccine review committee, has been accused of working as an adviser for a Shanghai-based Chinese pharmaceutical company.
Chen was allegedly listed as a “scientific adviser” on the Web site of Zhimeng Biopharma Inc (上海摯盟醫藥科技公司) in Shanghai, China, while he served as a committee member, sources said yesterday.
If the claims are true, it could mean Chen had contravened the law restricting government officials and employees from undertaking concurrent jobs in China and other countries.
Photo courtesy of Chen Pei-jer
Chen is also a professor at state-funded National Taiwan University (NTU) and a medical researcher at NTU Hospital.
Chen yesterday said he was not in a paid position at the Chinese firm.
He showed a letter from Zhimeng Biopharma stating that Chen’s scientific adviser role is an honorary title without any responsibility, obligation or payment, and “purely scientific advancement.”
However, critics said Chen and the company were trying to cover up their ties.
When resigning from the committee, Chen accused President Tsai Ing-wen (蔡英文) of pressuring the body to expedite the approval of the MVC-COV1901 vaccine being developed by Medigen Vaccine Biologics.
Citing his reasons for resigning his post, Chen said he believed the committee would have trouble staying neutral when reviewing domestic vaccine candidates.
The main problem was Tsai, as she said a locally developed COVID-19 vaccine is expected to be available late next month, Chen said, insinuating that the Food and Drug Administration could not resist pressure from the president and would expedite the vaccine’s approval.
New Taipei City Councilor Ho Po-wen (何博文) of the Democratic Progressive Party yesterday accused Chen of working to benefit China by sabotaging Taiwan’s vaccine development efforts.
Ho presented documents allegedly showing that Chen had close ties with universities and biotechnology companies in China, including Xiamen University.
Ho also said that Chen timed his resignation and public accusations just before the completion of phase 2 clinical trials of the vaccine, with Medigen scheduled to announce results of human trials soon.
“Chen is undermining Taiwan’s own COVID-19 vaccine to prevent it from reaching production. In his position as a committee member and a medical expert, he is saying Medigen’s vaccine is doomed to failure, and it would not pass clinical trials,” Ho said.
RETHINK? The defense ministry and Navy Command Headquarters could take over the indigenous submarine project and change its production timeline, a source said Admiral Huang Shu-kuang’s (黃曙光) resignation as head of the Indigenous Submarine Program and as a member of the National Security Council could affect the production of submarines, a source said yesterday. Huang in a statement last night said he had decided to resign due to national security concerns while expressing the hope that it would put a stop to political wrangling that only undermines the advancement of the nation’s defense capabilities. Taiwan People’s Party Legislator Vivian Huang (黃珊珊) yesterday said that the admiral, her older brother, felt it was time for him to step down and that he had completed what he
Taiwan has experienced its most significant improvement in the QS World University Rankings by Subject, data provided on Sunday by international higher education analyst Quacquarelli Symonds (QS) showed. Compared with last year’s edition of the rankings, which measure academic excellence and influence, Taiwanese universities made great improvements in the H Index metric, which evaluates research productivity and its impact, with a notable 30 percent increase overall, QS said. Taiwanese universities also made notable progress in the Citations per Paper metric, which measures the impact of research, achieving a 13 percent increase. Taiwanese universities gained 10 percent in Academic Reputation, but declined 18 percent
CHINA REACTS: The patrol and reconnaissance plane ‘transited the Taiwan Strait in international airspace,’ the 7th Fleet said, while Taipei said it saw nothing unusual The US 7th Fleet yesterday said that a US Navy P-8A Poseidon flew through the Taiwan Strait, a day after US and Chinese defense heads held their first talks since November 2022 in an effort to reduce regional tensions. The patrol and reconnaissance plane “transited the Taiwan Strait in international airspace,” the 7th Fleet said in a news release. “By operating within the Taiwan Strait in accordance with international law, the United States upholds the navigational rights and freedoms of all nations.” In a separate statement, the Ministry of National Defense said that it monitored nearby waters and airspace as the aircraft
UNDER DISCUSSION: The combatant command would integrate fast attack boat and anti-ship missile groups to defend waters closest to the coastline, a source said The military could establish a new combatant command as early as 2026, which would be tasked with defending Taiwan’s territorial waters 24 nautical miles (44.4km) from the nation’s coastline, a source familiar with the matter said yesterday. The new command, which would fall under the Naval Command Headquarters, would be led by a vice admiral and integrate existing fast attack boat and anti-ship missile groups, along with the Naval Maritime Surveillance and Reconnaissance Command, said the source, who asked to remain anonymous. It could be launched by 2026, but details are being discussed and no final timetable has been announced, the source